Shelia Violette
Founder at Q32 Bio, Inc.
Net worth: 56 904 $ as of 2024-04-29
Profile
Shelia Violette is the founder of Q32 Bio, Inc. (Massachusetts) and Q32 Bio, Inc., both founded in 2017.
She holds the title of Chief Scientific Officer at Q32 Bio, Inc. (Massachusetts) and Chief Scientific Officer & President-Research at Q32 Bio, Inc. Currently, Dr. Violette is an Advisor at Atlas Venture Advisors, Inc. since 2021.
Previously, she worked as an Immunology Director at Biogen, Inc., Director at CytImmune Sciences, Inc. from 2021 to 2023, Principal at Repligen Corp., Principal at ARIAD Pharmaceuticals, Inc., and Vice President-Research at Stromedix, Inc. Dr. Violette obtained her doctorate degree from Yale University in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.02% | 2024-03-24 | 2,015 ( 0.02% ) | 56 904 $ | 2024-04-29 |
Shelia Violette active positions
| Companies | Position | Start |
|---|---|---|
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Founder | 2016-12-31 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | 2020-12-31 |
Former positions of Shelia Violette
| Companies | Position | End |
|---|---|---|
CytImmune Sciences, Inc.
 CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Director/Board Member | 2023-05-31 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Shelia Violette
| Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 5 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
CytImmune Sciences, Inc.
CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Health Technology |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Shelia Violette